FDA Drug Recalls

Recalls / Class II

Class IID-1277-2015

Product

Captopril Tablets, USP, 100 mg Tablets, Packaged in 100 Count Bottles, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-0905-01.

Affected lot / code info
Lot #: LM11354, Expiry: 7/31/2015; Lot #: LM11355, Expiry: 7/31/2015; Lot #: LM11374, Expiry: 7/31/2015; Lot #: LM11626, Expiry: 8/31/2015; Lot #: LM12004, Expiry: 11/30/2015; Lot #: LM12005, Expiry: 11/30/2015; Lot #: LN10080, Expiry: 10/31/2015; Lot #: LN10393, Expiry: 1/31/2016; Lot #: LN10447, Expiry: 1/31/2016; Lot #: LN10736, Expiry: 2/29/2016; Lot #: LN11316, Expiry: 7/31/2016.

Why it was recalled

CGMP Deviations: Firm did not adequately investigate customer complaints.

Recalling firm

Firm
Wockhardt Usa Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
20 Waterview Blvd Ste 3, N/A, Parsippany, New Jersey 07054-1271

Distribution

Quantity
68,969 Bottles
Distribution pattern
U.S. Nationwide including Puerto Rico.

Timeline

Recall initiated
2015-04-22
FDA classified
2015-07-17
Posted by FDA
2015-07-29
Terminated
2018-05-09
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1277-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.